These newly uncovered evidence establishes a connection between SOX2/SOX9 gene regulation and TGF-β signaling and identifies the TME as an important factor in promoting treatment resistance in cancer cells expressing SOX2 and/or SOX9. The gene discussed is SOX2; the disease is cancer.